Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s Why

Biogen Inc. (NASDAQ:BIIB) is 1 of the champion aesculapian probe stocks to bargain according to hedge funds. On February 10, Wedbush lifted the terms people connected Biogen Inc. (NASDAQ:BIIB) to $187 from $178, maintaining a Neutral standing connected the shares. The steadfast told investors that Biogen Inc. (NASDAQ:BIIB) delivered different  top-/bottom-line bushed successful its fiscal Q4 and afloat twelvemonth 2025 fiscal results, and commended the management’s efforts successful realigning the outgo base. However, it added that gross maturation drivers are the captious missing portion for the turnaround story.

RBC Capital besides adjusted the terms people connected Biogen Inc. (NASDAQ:BIIB) to $233 from $217 connected February 9, maintaining an Outperform standing connected the shares. According to the firm, the institution successfully delivered its cardinal nonsubjective of showing stableness and predictability successful the quarter, some successful guidance and numbers. It believes that the institution has a coagulated instauration for a catalyst-rich adjacent year, supported by factors specified arsenic coagulated commercialized execution, maturation crossed cardinal franchises, and improved disbursal discipline.

Biogen Inc. (NASDAQ:BIIB) besides received a standing update from BMO Capital the aforesaid day, which revised the terms people connected the banal to $196 from $165 and maintained a Market Perform standing connected the shares aft its fiscal Q4 net beat.

Biogen Inc. (NASDAQ:BIIB) is simply a planetary biopharmaceutical institution that discovers, develops, and delivers precocious therapies for superior diseases crossed the globe. Its medicine portfolio treats aggregate sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS). The institution has an elaborate marketed merchandise portfolio for MS, including TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. It besides markets SPINRAZA to dainty SMA, SKYCLARYS for the attraction of Friedreich’s Ataxia, and different drugs.

While we admit the imaginable of BIIB arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.